These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 3528345

  • 1. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK, Bhatia VN, Harikrishnan S.
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [Abstract] [Full Text] [Related]

  • 2. Clofazimine-resistant M. leprae.
    Levy L.
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):137-40. PubMed ID: 3519801
    [No Abstract] [Full Text] [Related]

  • 3. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ, Norman G, Joseph GA, Daniel S, Job CK.
    Indian J Lepr; 2002 Mar; 74(4):301-12. PubMed ID: 12624978
    [Abstract] [Full Text] [Related]

  • 4. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M, Kashiwabara Y, Namisato M.
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [Abstract] [Full Text] [Related]

  • 5. Secondary sulphone resistance in leprosy (Report of a case).
    Lal S, Jaganath C, Garg BR, Paneerselvam R.
    Lepr India; 1980 Apr; 52(2):299-301. PubMed ID: 7005542
    [Abstract] [Full Text] [Related]

  • 6. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
    Sekar B, Elangeswaran N, Jayarama E, Rajendran M, Kumar SS, Vijayaraghavan R, Anandan D, Arunagiri K.
    Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888
    [Abstract] [Full Text] [Related]

  • 7. Dapsone resistance in leprosy.
    Browne SG.
    Trans St Johns Hosp Dermatol Soc; 1973 Sep; 59(2):225-9. PubMed ID: 4602407
    [No Abstract] [Full Text] [Related]

  • 8. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
    Karat AB.
    Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966
    [No Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
    Dhople AM, Lamoureux LC, Gardner GD.
    Indian J Lepr; 1991 Jun; 63(2):166-79. PubMed ID: 1664440
    [Abstract] [Full Text] [Related]

  • 10. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
    Shepard CC, Rees RJ, Levy L, Pattyn SR, Baohong J, Dela Cruz EC.
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
    [Abstract] [Full Text] [Related]

  • 11. Clofazimine in the treatment of dapsone resistant leprosy.
    Taylor PM, Alexander R.
    Lepr India; 1976 Oct; 48(4 Suppl):709-12. PubMed ID: 800234
    [Abstract] [Full Text] [Related]

  • 12. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
    Levy L, Shepard CC, Fasal P.
    Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
    [No Abstract] [Full Text] [Related]

  • 13. The chemotherapy of leprosy. Part 1.
    Ellard GA.
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):704-16. PubMed ID: 2280120
    [No Abstract] [Full Text] [Related]

  • 14. Dapsone drug resistance in the MDT era.
    Roche PW, Neupane KD, Failbus SS, Butlin CR.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence of drug resistance in Dharmapuri and A. Pallipatti areas of Tamil Nadu.
    Sreevatsa, Ramu G, Desikan KV.
    Indian J Lepr; 1985 Sep; 57(2):376-82. PubMed ID: 3908580
    [Abstract] [Full Text] [Related]

  • 16. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
    Dhople AM.
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
    [Abstract] [Full Text] [Related]

  • 17. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
    Browne SG.
    Int J Lepr Other Mycobact Dis; 1969 Jun; 37(3):296-301. PubMed ID: 4906048
    [No Abstract] [Full Text] [Related]

  • 18. Drug resistance in leprosy: lessons from past and future perspective.
    Gupta UD, Katoch VM.
    Indian J Lepr; 1999 Jun; 71(4):451-63. PubMed ID: 10804973
    [Abstract] [Full Text] [Related]

  • 19. Primary sulphone resistance. A preliminary report.
    Girdhar BK, Sreevatsa, Desikan KV.
    Lepr India; 1978 Jul; 50(3):352-5. PubMed ID: 359924
    [Abstract] [Full Text] [Related]

  • 20. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
    Balakrishnan S, Seshadri PS, Neelan PN, Venkataramaniah HN, Harikrishnan S, Bhatia VN.
    Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.